drugset / Trial / NCT01846429

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

NCT01846429

NaSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to: * Determine how well people tolerate sodium bicarbonate taken by mouth in higher doses than those usually given for heartburn. * Determine if sodium bicarbonate can reduce cancer-related pain.

Timeline

Start
2013-09
Primary completion
2014-12
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium bicarbonate Diagnostic / imaging agent 9000 mg Oral
Subject sodium bicarbonate Diagnostic / imaging agent 18000 mg Oral
Subject sodium bicarbonate Diagnostic / imaging agent 27000 mg Oral
Subject sodium bicarbonate Diagnostic / imaging agent 36000 mg Oral